[HTML][HTML] Cellular interactions in the tumor microenvironment: the role of secretome
BR da Cunha, C Domingos, ACB Stefanini… - Journal of …, 2019 - ncbi.nlm.nih.gov
Over the past years, it has become evident that cancer initiation and progression depends
on several components of the tumor microenvironment, including inflammatory and immune …
on several components of the tumor microenvironment, including inflammatory and immune …
[图书][B] Qualitative health research: Creating a new discipline
JM Morse - 2016 - taylorfrancis.com
The leading figure in qualitative health research (QHR), Janice M. Morse, asserts that QHR
is its own separate discipline—distinct from both traditional health research and other kinds …
is its own separate discipline—distinct from both traditional health research and other kinds …
Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome
SM Varnum, DN Streblow, ME Monroe, P Smith… - Journal of …, 2004 - Am Soc Microbiol
Human cytomegalovirus (HCMV), a member of the herpesvirus family, is a large complex
enveloped virus composed of both viral and cellular gene products. While the sequence of …
enveloped virus composed of both viral and cellular gene products. While the sequence of …
Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications
C Osborne, P Wilson, D Tripathy - The oncologist, 2004 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to:
Differentiate between the actions of oncogenes and tumor suppressor genes in the …
Differentiate between the actions of oncogenes and tumor suppressor genes in the …
[HTML][HTML] Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications
Recent advances in proteomics technologies provide tremendous opportunities for
biomarker-related clinical applications; however, the distinctive characteristics of human …
biomarker-related clinical applications; however, the distinctive characteristics of human …
Secreted proteins as a fundamental source for biomarker discovery
M Stastna, JE Van Eyk - Proteomics, 2012 - Wiley Online Library
The proteins secreted by various cells (the secretomes) are a potential rich source of
biomarkers as they reflect various states of the cells at real time and at given conditions. To …
biomarkers as they reflect various states of the cells at real time and at given conditions. To …
Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery
JE Celis, P Gromov, T Cabezon, JMA Moreira… - Molecular & Cellular …, 2004 - ASBMB
Clinical cancer proteomics aims at the identification of markers for early detection and
predictive purposes, as well as to provide novel targets for drug discovery and therapeutic …
predictive purposes, as well as to provide novel targets for drug discovery and therapeutic …
The cancer cell secretome: a good source for discovering biomarkers?
MP Pavlou, EP Diamandis - Journal of proteomics, 2010 - Elsevier
Cancer is a leading cause of death. Early detection is usually associated with better clinical
outcomes. Recent advances in genomics and proteomics raised hopes that new biomarkers …
outcomes. Recent advances in genomics and proteomics raised hopes that new biomarkers …
Macrophage responses to silica nanoparticles are highly conserved across particle sizes
KM Waters, LM Masiello, RC Zangar… - Toxicological …, 2009 - academic.oup.com
Concerns about the potential adverse health effects of engineered nanoparticles stems in
part from the possibility that some materials display unique chemical and physical properties …
part from the possibility that some materials display unique chemical and physical properties …
The cancer secretome: a reservoir of biomarkers
H Xue, B Lu, M Lai - Journal of translational medicine, 2008 - Springer
Biomarkers are pivotal for cancer detection, diagnosis, prognosis and therapeutic
monitoring. However, currently available cancer biomarkers have the disadvantage of …
monitoring. However, currently available cancer biomarkers have the disadvantage of …